Client: Biosun Pharmed
Location: Middle East
Surface Area: 1002 m² and 1600 m²
Year Completed: 2021 and 2022

Turnkey cleanroom project of GMP Grades B, C and D for vaccine production facility and a turnkey cleanroom project of GMP Grades C and D for production of peptides (production floor and plant room).

Biosun Pharmed is a company that specialises in production of vaccines and healing drugs for domestic and foreign markets in accordance with state-of-the-art international quality standards. The company has several manufacturing sites for peptide manufacturing, biosmilar, vaccine, as well as a research and development site.

Client: Pharmarolly
Location: North Macedonia
Surface Area: 400 m²
Year Completed: 2020

Complete turnkey cleanroom project of GMP Grade D intended for drying, extraction, packaging and warehouse of medical cannabis production.

Pharmarolly is a pharmaceutical company producing high quality medical cannabis extras. The company is producing different forms of medical cannabis products: production of dry flower and of full spectrum crude cannabis oil as well as distillate.

Client: Nextpharma 
Location: Finland
Surface Area: 120 m²
Year Completed:

Complete cleanroom system that creates a controlled C Class & D Class Material Airlocks, CNC Area (Technical Area & Process Electronic), C Class & D Class Personal Airlocks, C Class Compounding & BFS BP6 Rooms. The cleanrooms were designed and constructed according to the standard ISO 14644-1:2015 and validated according to current EU GMP vol. 4.

NextPharma is a pharmaceutical contract development and manufacturing organisation serving worldwide markets. The company provides a full range of pharmaceutical services across the entire supply chain, including pharmaceutical development, clinical trials and analytical services, commercial manufacturing and packaging within a broad range of pharmaceutical dosage forms.

Client: Cinnagen Ilac
Location: Turkey
Surface Area: 1500 m²
Year Completed: 2019

Complete turnkey cleanroom project of GMP Grade B, C and D intended for producing biopharmaceutical products in bulk and as finished products. The project was intended for the following facility areas: warehouse, fill and finish area, packing area, bioreactor area, quality control and research&development lab.

CinnaGen İlaç is a company which specialises in producing biosimilar products and in exporting biosimilar products worldwide. Their Çerkezköy production facility’s main operational purpose is the development and production of monoclonal antibody (mAb) drugs used in the treatment of cancer, multiple sclerosis, blood diseases, rheumatism and metabolic disorders, starting from the Master Cell Bank (MCB).

Client:  Chipita
Location: Slovakia
Surface Area: 1800  m²
Year Completed:   2022

Complete turnkey cleanroom project of ISO 5 and ISO 7 areas for the Client’s new plant dedicated to expanding its bakery activities in Europe. The new factory is equipped with a cleanroom dedicated to pastry production. Baked pastries enter the cleanroom from the oven outlet and leave the cleanroom area after the packaging lines, where they are individually packaged.

Chipita Slovakia s.r.o. is located in Bratislava-Staré Mesto, and is an international company which originated from Greece. The company is currently present internationally in 3 major product groups- croissants and similar dough products, bread based baked snacks (Bake Rolls) and other products. 

Chipita operates through production plants in several countries in Europe and USA and owns 14 production plants in total.

Client: CinnaGen Co. Facility
Location:  Middle East
Surface Area: 700 m² , 2000 m² & 5000 m²
Year Completed:  2015, 2016 and 2020

Three complete turnkey cleanroom projects of grades B, C and D, for producing biopharmaceutical products in bulk, as well as finished products separated into E. coli production, water treatment, quality assurance, quality control and cell bank.

CinnaGen Co. is the biggest manufacturer and exporter of hi-tech products in biotechnology and related fields in the Middle East region. The company is developing biosimilar candidates in the areas of Immunological diseases, MS, Infertility, Diabetes, Kidney diseases, Osteoporosis, Hormone disorders and Oncology as well as providing contract research development services.

Client: Confidential
Location: Finland
Surface Area: 532 m²
Year Completed: 2022

Complete turnkey cleanroom project of GMP Grade D for production of nanosized active pharmaceutical ingredients (API) and pharmaceutical intermediates under Good Manufacturing Practices for preclinical and clinical trials for the customer pharmaceutical companies.

The Client is a pioneering company dedicated to providing nanoparticle engineering services that enable more patients around the world to benefit from next-generation drug therapies.